A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia (original) (raw)

• Harrison PJ . The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593–624.
  Article PubMed Google Scholar
• Kaufmann WE, Moser HW . Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 2000; 10: 981–991.
  Article CAS PubMed Google Scholar
• Eastwood SL . The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol 2004; 59: 47–72.
  Article CAS PubMed Google Scholar
• Lewis DA, Levitt P . Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002; 25: 409–432.
  Article CAS PubMed Google Scholar
• McGlashan TH, Hoffman RE . Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000; 57: 637–648.
  Article CAS PubMed Google Scholar
• Woods BT . Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998; 155: 1661–1670.
  Article CAS PubMed Google Scholar
• Selemon LD, Mrzljak J, Kleinman JE, Herman MM, Goldman-Rakic PS . Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. Arch Gen Psychiatry 2003; 60: 69–77.
  Article PubMed Google Scholar
• Black JE, Kodish IM, Grossman AW, Klintsova AY, Orlovskaya D, Vostrikov V et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry 2004; 161: 742–744.
  Article PubMed Google Scholar
• Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65: 446–453.
  Article CAS PubMed PubMed Central Google Scholar
• Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF . Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 2006; 81: 47–63.
  Article PubMed Google Scholar
• Glantz LA, Lewis DA . Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65–73.
  Article CAS PubMed Google Scholar
• Hill SK, Ragland JD, Gur RC, Gur RE . Neuropsychological differences among empirically derived clinical subtypes of schizophrenia. Neuropsychology 2001; 15: 492–501.
  Article CAS PubMed Google Scholar
• Kolluri N, Sun Z, Sampson AR, Lewis DA . Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 2005; 162: 1200–1202.
  Article PubMed Google Scholar
• Kolomeets NS, Orlovskaya DD, Rachmanova VI, Uranova NA . Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse 2005; 57: 47–55.
  Article CAS PubMed Google Scholar
• Stephan KE, Baldeweg T, Friston KJ . Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 2006; 59: 929–939.
  Article CAS PubMed Google Scholar
• Cullen TJ, Walker MA, Eastwood SL, Esiri MM, Harrison PJ, Crow TJ . Anomalies of asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in schizophrenia. Br J Psychiatry 2006; 188: 26–31.
  Article PubMed Google Scholar
• Selemon LD, Goldman-Rakic PS . The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999; 45: 17–25.
  Article CAS PubMed Google Scholar
• Selemon LD . Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr Bull 2001; 27: 349–377.
  Article CAS PubMed Google Scholar
• Moghaddam B . Bringing order to the glutamate chaos in schizophrenia. Neuron 2003; 40: 881–884.
  Article CAS PubMed Google Scholar
• Tsai G, Coyle JT . Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002; 42: 165–179.
  Article CAS PubMed Google Scholar
• Kennedy MB, Beale HC, Carlisle HJ, Washburn LR . Integration of biochemical signalling in spines. Nat Rev Neurosci 2005; 6: 423–434.
  Article CAS PubMed Google Scholar
• Okabe S . Molecular anatomy of the postsynaptic density. Mol Cell Neurosci 2007; 34: 503–518.
  Article CAS PubMed Google Scholar
• Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH . NMDA receptors and schizophrenia. Curr Opin Pharmacol 2007; 7: 48–55.
  Article CAS PubMed Google Scholar
• Bernstein HG, Becker A, Keilhoff G, Spilker C, Gorczyca WA, Braunewell KH et al. Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats. Neurosci Lett 2003; 339: 95–98.
  Article CAS PubMed Google Scholar
• Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG . Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 2004; 126: 591–598.
  Article CAS PubMed Google Scholar
• Dean B, Crook JM, Pavey G, Opeskin K, Copolov DL . Muscarinic 1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia. Mol Psychiatry 2000; 5: 203–207.
  Article CAS PubMed Google Scholar
• Yamada S, Esaki Y, Mizutani T . Intracranial cavity volume can be accurately estimated from the weights of intracranial contents: confirmation by the dental plaster casting method. Neuropathol Appl Neurobiol 1999; 25: 341–344.
  Article CAS PubMed Google Scholar
• Bernstein HG, Sahin J, Smalla KH, Gundelfinger ED, Bogerts B, Kreutz MR . A reduced number of cortical neurons show increased caldendrin protein levels in chronic schizophrenia. Schizophr Res 2007; 96: 246–256.
  Article PubMed Google Scholar
• Danos P, Baumann B, Kramer A, Bernstein HG, Stauch R, Krell D et al. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr Res 2003; 60: 141–155.
  Article PubMed Google Scholar
• Smalla KH, Matthies H, Langnase K, Shabir S, Bockers TM, Wyneken U et al. The synaptic glycoprotein neuroplastin is involved in long-term potentiation at hippocampal CA1 synapses. Proc Natl Acad Sci USA 2000; 97: 4327–4332.
  Article CAS PubMed PubMed Central Google Scholar
• Van den Oever MC, Spijker S, Li KW, Jimenez CR, Koya E, Van der Schors RC et al. A proteomics approach to identify long-term molecular changes in rat medial prefrontal cortex resulting from sucrose self-administration. J Proteome Res 2006; 5: 147–154.
  Article CAS PubMed Google Scholar
• Li KW, Hornshaw MP, Van Der Schors RC, Watson R, Tate S, Casetta B et al. Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J Biol Chem 2004; 279: 987–1002.
  Article CAS PubMed Google Scholar
• Bernstein HG, Smalla KH, Bogerts B, Gordon-Weeks PR, Beesley PW, Gundelfinger ED et al. The immunolocalization of the synaptic glycoprotein neuroplastin differs substantially between the human and the rodent brain. Brain Res 2007; 1134: 107–112.
  Article CAS PubMed Google Scholar
• Smalla KH, Seidenbecher CI, Tischmeyer W, Schicknick H, Wyneken U, Bockers TM et al. Kainate-induced epileptic seizures induce a recruitment of caldendrin to the postsynaptic density in rat brain. Brain Res Mol Brain Res 2003; 116: 159–162.
  Article CAS PubMed Google Scholar
• Wendholt D, Spilker C, Schmitt A, Dolnik A, Smalla KH, Proepper C et al. ProSAP-interacting protein 1 (ProSAPiP1), a novel protein of the postsynaptic density that links the spine-associated Rap-Gap (SPAR) to the scaffolding protein ProSAP2/Shank3. J Biol Chem 2006; 281: 13805–13816.
  Article CAS PubMed Google Scholar
• tom Dieck S, Sanmarti-Vila L, Langnaese K, Richter K, Kindler S, Soyke A et al. Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J Cell Biol 1998; 142: 499–509.
  Article CAS PubMed Google Scholar
• Dieterich DC, Karpova A, Mikhaylova M, Zdobnova I, Koenig I, Landwehr M et al. Caldendrin–Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus. PLoS Biol 2008; 6: 286–306.
  Article CAS Google Scholar
• Spilker C, Acuna Sanhueza GA, Bockers TM, Kreutz MR, Gundelfinger ED . SPAR2, a novel SPAR-related protein with GAP activity for Rap1 and Rap2. J Neurochem 2008; 104: 187–201.
  CAS PubMed Google Scholar
• Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867–875.
  Article CAS PubMed Google Scholar
• Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED et al. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 1999; 28: 655–662.
  Article CAS PubMed Google Scholar
• Bernstein HG, Seidenbecher CI, Smalla KH, Gundelfinger ED, Bogerts B, Kreutz MR . Distribution and cellular localization of caldendrin immunoreactivity in adult human forebrain. J Histochem Cytochem 2003; 51: 1109–1112.
  Article CAS PubMed Google Scholar
• Hsu SM, Soban E . Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 1982; 30: 1079–1082.
  Article CAS PubMed Google Scholar
• Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM et al. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics 2006; 5: 1158–1170.
  Article CAS PubMed Google Scholar
• Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, Blackstock WP et al. Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem 2006; 97: 16–23.
  Article CAS PubMed Google Scholar
• Dosemeci A, Tao-Cheng JH, Vinade L, Jaffe H . Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis. Biochem Biophys Res Commun 2006; 339: 687–694.
  Article CAS PubMed Google Scholar
• Jordan BA, Fernholz BD, Boussac M, Xu C, Grigorean G, Ziff EB et al. Identification and verification of novel rodent postsynaptic density proteins. Mol Cell Proteomics 2004; 3: 857–871.
  Article CAS PubMed Google Scholar
• Li K, Hornshaw MP, van Minnen J, Smalla KH, Gundelfinger ED, Smit AB . Organelle proteomics of rat synaptic proteins: correlation-profiling by isotope-coded affinity tagging in conjunction with liquid chromatography-tandem mass spectrometry to reveal post-synaptic density specific proteins. J Proteome Res 2005; 4: 725–733.
  Article CAS PubMed Google Scholar
• Peng J, Kim MJ, Cheng D, Duong DM, Gygi SP, Sheng M . Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem 2004; 279: 21003–21011.
  Article CAS PubMed Google Scholar
• Trinidad JC, Specht CG, Thalhammer A, Schoepfer R, Burlingame AL . Comprehensive identification of phosphorylation sites in postsynaptic density preparations. Mol Cell Proteomics 2006; 5: 914–922.
  Article CAS PubMed Google Scholar
• Yoshimura Y, Yamauchi Y, Shinkawa T, Taoka M, Donai H, Takahashi N et al. Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J Neurochem 2004; 88: 759–768.
  Article CAS PubMed Google Scholar
• Alexander-Kaufman K, James G, Sheedy D, Harper C, Matsumoto I . Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study. Mol Psychiatry 2006; 11: 56–65.
  Article CAS PubMed Google Scholar
• Mishra S, Murphy LC, Nyomba BL, Murphy LJ . Prohibitin: a potential target for new therapeutics. Trends Mol Med 2005; 11: 192–197.
  Article CAS PubMed Google Scholar
• Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684–697.
  Article CAS PubMed Google Scholar
• Kalus P, Muller TJ, Zuschratter W, Senitz D . The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 2000; 11: 3621–3625.
  Article CAS PubMed Google Scholar
• Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000; 48: 99–109.
  Article CAS PubMed Google Scholar
• Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 2005; 62: 379–386.
  Article PubMed Google Scholar
• Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D . Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006; 6: 3414–3425.
  Article CAS PubMed Google Scholar
• Clark D, Dedova I, Cordwell S, Matsumoto I . A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry 2006; 11: 459–470.
  Article CAS PubMed Google Scholar
• Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, et al, The Stanley Neuropathology Consortium. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol Psychiatry 2000; 5: 142–149.
  Article CAS PubMed Google Scholar
• Mei J, Kolbin D, Kao HT, Porton B . Protein expression profiling of postmortem brain in schizophrenia. Schizophr Res 2006; 84: 204–213.
  Article PubMed Google Scholar
• Novikova SI, He F, Cutrufello NJ, Lidow MS . Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol Dis 2006; 23: 61–76.
  Article CAS PubMed Google Scholar
• Pennington K, Beasley CL, Dicker P, Fagan A, English J, Pariante CM et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry, published online 16 October 2007; e-pub ahead of print.
• Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A et al. Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J Neurosci Res 2003; 71: 526–533.
  Article CAS PubMed Google Scholar
• Arion D, Unger T, Lewis DA, Levitt P, Mirnics K . Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007; 63: 711–721.
  Article CAS Google Scholar
• Dean B, Keriakous D, Scarr E, Thomas EA . Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust N Z J Psychiatry 2007; 41: 308–320.
  Article PubMed Google Scholar
• DeLisi LE, Fleischhaker W . Schizophrenia research in the era of the genome. Curr Opin Psychiatry 2007; 20: 109–110.
  Article PubMed Google Scholar
• Saito A, Fujikura-Ouchi Y, Kuramasu A, Shimoda K, Akiyama K, Matsuoka H et al. Association study of putative promoter polymorphisms in the neuroplastin gene and schizophrenia. Neurosci Lett 2007; 411: 168–173.
  Article CAS PubMed Google Scholar
• Sivagnanasundaram S, Fletcher D, Hubank M, Illingworth E, Skuse D, Scambler P . Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia. Brain Res 2007; 1139: 48–59.
  Article CAS PubMed Google Scholar
• Eastwood SL, Harrison PJ . Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 2000; 5: 425–432.
  Article CAS PubMed Google Scholar
• Harrison PJ, Eastwood SL . Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 1998; 352: 1669–1673.
  Article CAS PubMed Google Scholar
• Di Maria E, Gulli R, Begni S, De Luca A, Bignotti S, Pasini A et al. Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. Am J Med Genet B Neuropsychiatr Genet 2004; 128: 27–29.
  Article Google Scholar
• Iasevoli F, Polese D, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A . Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis. Neurosci Lett 2007; 416: 1–5.
  Article CAS PubMed Google Scholar
• Malhotra AK, Breier A, Goldman D, Picken L, Pickar D . The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. Neuropsychopharmacology 1998; 19: 445–448.
  Article CAS PubMed Google Scholar
• Li KW, Miller S, Klychnikov O, Loos M, Stahl-Zeng J, Spijker S et al. Quantitative proteomics and protein network analysis of hippocampal synapses of CaMKIIalpha mutant mice. J Proteome Res 2007; 6: 3127–3133.
  Article CAS PubMed Google Scholar
• Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K et al. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 2002; 83: 797–806.
  Article CAS PubMed Google Scholar
• Sutton MA, Schuman EM . Dendritic protein synthesis, synaptic plasticity, and memory. Cell 2006; 127: 49–58.
  Article CAS PubMed Google Scholar
• Carboni L, Vighini M, Piubelli C, Castelletti L, Milli A, Domenici E . Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. Eur Neuropsychopharmacol 2006; 16: 521–537.
  Article CAS PubMed Google Scholar
• Vercauteren FG, Bergeron JJ, Vandesande F, Arckens L, Quirion R . Proteomic approaches in brain research and neuropharmacology. Eur J Pharmacol 2004; 500: 385–398.
  Article CAS PubMed Google Scholar
• Yang MS, Yu L, Guo TW, Zhu SM, Liu HJ, Shi YY et al. Evidence for association between single nucleotide polymorphisms in T complex protein 1 gene and schizophrenia in the Chinese Han population. J Med Genet 2004; 41: e63.
  Article CAS PubMed PubMed Central Google Scholar
• La Y, Wan C, Zhu H, Yang Y, Chen Y, Pan Y et al. Hippocampus protein profiling reveals aberration of malate dehydrogenase in chlorpromazine/clozapine treated rats. Neurosci Lett 2006; 408: 29–34.
  Article CAS PubMed Google Scholar
• Stone WS, Faraone SV, Su J, Tarbox SI, Van Eerdewegh P, Tsuang MT . Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. Am J Med Genet B Neuropsychiatr Genet 2004; 127: 5–10.
  Article Google Scholar
• Burbaeva G, Savushkina OK, Boksha IS . Creatine kinase BB in brain in schizophrenia. World J Biol Psychiatry 2003; 4: 177–183.
  Article PubMed Google Scholar
• Kunugi H, Kato T, Fukuda R, Tatsumi M, Sakai T, Nanko S . Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders. J Neural Transm 2002; 109: 213–218.
  Article CAS PubMed Google Scholar
• Minoretti P, Politi P, Coen E, Di Vito C, Bertona M, Bianchi M et al. The T393C polymorphism of the GNAS1 gene is associated with deficit schizophrenia in an Italian population sample. Neurosci Lett 2006; 397: 159–163.
  Article CAS PubMed Google Scholar
• Tani M, Mui K, Minami Y, Kiriike N . Association of a GTP-binding protein Go alpha subunit mutation with schizophrenia. Mol Psychiatry 2001; 6: 359.
  Article CAS PubMed Google Scholar
• Ventriglia M, Bocchio Chiavetto L, Bonvicini C, Tura GB, Bignotti S, Racagni G et al. Allelic variation in the human prodynorphin gene promoter and schizophrenia. Neuropsychobiology 2002; 46: 17–21.
  Article CAS PubMed Google Scholar
• Zhang CS, Tan Z, Lu L, Wu SN, He Y, Gu NF et al. Polymorphism of Prodynorphin promoter is associated with schizophrenia in Chinese population. Acta Pharmacol Sin 2004; 25: 1022–1026.
  CAS PubMed Google Scholar
• Li Z, Okamoto K, Hayashi Y, Sheng M . The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004; 119: 873–887.
  Article CAS PubMed Google Scholar
• Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, Back JW et al. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J 2000; 19: 2444–2451.
  Article CAS PubMed PubMed Central Google Scholar
• Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, Sievers C et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 2005; 7: 837–843.
  Article CAS PubMed Google Scholar